Drugs / MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03056664 | Jan 2017 → Dec 2019 | Crohn disease, anal fistula | Sixth Affiliated Hospital, Sun Yat-sen University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03056664 ↗ |
| Known as | MSC injection 01 | “Biological: MSC injection 01” NCT03056664 ↗ |
| Modality | Cell therapy | “Biological: MSC injection 01” NCT03056664 ↗ |
| Route | Other | “Local MSC injection in peri-anal with a dose of 3×10E6/kg” NCT03056664 ↗ |